烏鴉座製藥公司
DE ˙ DB ˙ US2210151005
€10.25 ↑0.31 (3.12%)
2026-06-04
分享價格
SecurityDE:C17 / Corvus Pharmaceuticals, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership3,565,992 shares
Latest Disclosed Value $ 52,170,463
State Street Corp reports 27.89% increase in ownership of C17 / Corvus Pharmaceuticals, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 3,565,992 shares of Corvus Pharmaceuticals, Inc. (DE:C17) valued at $40,438,349 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,788,223 shares of Corvus Pharmaceuticals, Inc.. This represents a change in shares of 27.89% during the quarter. The current value of the position is $36,551,418 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 3,565,992 777,769 27.89 52,170 143.00 0.0018
2026-02-13 2025-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 2,788,223 1,781,904 177.07 21,469 189.50 0.0007
2025-11-14 2025-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 1,006,319 341,551 51.38 7,417 178.90 0.0003
2025-08-14 2025-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 664,768 434,730 188.98 2,659 263.75 0.0001
2025-05-15 2025-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 230,038 24,500 11.92 732 -33.48 0.0000
2025-02-14 2024-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 205,538 27,292 15.31 1,100 16.79 0.0000
2024-11-14 2024-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 178,246 57,943 48.16 941 331.65 0.0000
2024-08-14 2024-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 120,303 0 0.00 219 1.87 0.0000
2024-05-15 2024-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 120,303 -18,100 -13.08 214 -11.93 0.0000
2024-02-14 2023-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 138,403 0 0.00 244 20.30 0.0000
2023-11-14 2023-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 138,403 0 0.00 202 -36.08 0.0000
2023-08-14 2023-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 138,403 25,800 22.91 317 209.80 0.0000
2023-05-15 2023-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 112,603 0 0.00 102 7.37 0.0000
2023-05-15 2022-12-31 13F/A-99 CORVUS PHARMACEUTICALS COM 221015100 112,603 0 0.00 96 3.26 0.0000
2023-05-15 2022-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 112,603 0 96 0.0000
2022-11-15 2022-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 112,603 0 0.00 92 -17.12 0.0000
2022-08-15 2022-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 112,603 0 0.00 111 -40.00 0.0000
2022-05-16 2022-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 112,603 12,203 12.15 185 -23.55 0.0000
2022-02-14 2021-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 100,400 34,000 51.20 242 -24.61 0.0000
2021-11-15 2021-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 66,400 36,800 124.32 321 306.33 0.0000
2021-08-16 2021-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 29,600 8,301 38.97 79 23.44 0.0000
2019-11-14 2019-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 21,299 789 3.85 64 -16.88 0.0000
2019-08-14 2019-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 20,510 -191,807 -90.34 77 -90.98 0.0000
2019-05-15 2019-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 212,317 8,541 4.19 854 14.17 0.0001
2019-02-12 2018-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 203,776 20,552 11.22 748 -52.42 0.0001
2018-11-09 2018-09-30 13F CORVUS PHARMACEUTICALS Common equity shares 221015100 183,224 16,586 9.95 1,572 -14.00 0.0001
2018-08-14 2018-06-30 13F CORVUS PHARMACEUTICALS Common equity shares 221015100 166,638 70,159 72.72 1,828 64.68 0.0002
2018-05-15 2018-03-31 13F CORVUS PHARMACEUTICALS Common equity shares 221015100 96,479 -538 -0.55 1,110 10.56 0.0001
2018-02-14 2017-12-31 13F CORVUS PHARMACEUTICALS Common equity shares 221015100 97,017 27,664 39.89 1,004 -9.06 0.0001
2017-11-14 2017-09-30 13F CORVUS PHARMACEUTICALS Common equity shares 221015100 69,353 6,878 11.01 1,104 46.03 0.0001
2017-08-14 2017-06-30 13F CORVUS PHARMACEUTICALS Common equity shares 221015100 62,475 9,779 18.56 756 -30.83 0.0001
2017-05-15 2017-03-31 13F CORVUS PHARMACEUTICALS Common equity shares 221015100 52,696 1,437 2.80 1,093 49.32 0.0001
2017-02-09 2016-12-31 13F CORVUS PHARMACEUTICALS Common equity shares 221015100 51,259 -2,849 -5.27 732 -17.75 0.0001
2017-01-13 2016-09-30 13F/A-1 CORVUS PHARMACEUTICALS Common equity shares 221015100 54,108 25,513 89.22 890 118.67 0.0001
2016-11-14 2016-09-30 13F CORVUS PHARMACEUTICALS Common equity shares 221015100 54,108 890
2016-08-12 2016-06-30 13F CORVUS PHARMACEUTICALS Common equity shares 221015100 28,595 28,595 407 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.